<DOC>
	<DOCNO>NCT02720042</DOCNO>
	<brief_summary>The purpose study collect additional data safety performance Phasix™ Mesh subject require VHWG Grade 3 midline hernia repair .</brief_summary>
	<brief_title>Study Phasix™ Mesh VHWG Grade 3 Midline Hernia Repair</brief_title>
	<detailed_description>Approximately 85 subject , approximately 12 site across Europe enrol treat study use Phasix™ Mesh . All treat subject follow 2 year post-implantation .</detailed_description>
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Hernia , Abdominal</mesh_term>
	<mesh_term>Incisional Hernia</mesh_term>
	<criteria>Subject must diagnose incisional midline hernia . Subject VHWG Grade 3 hernia ( define protocol ) . Size hernia ≥ 10 cm2 . Subject must willing undergo plan retrorectus hernia repair ( onlay allow exception retrorectus placement achieve ; use absorbable suture ) without Component Separation Technique . Subject &gt; 4 previous repair hernia observation . Body Mass Index ( BMI ) &gt; 35 kg/m2 . The subject , suspect place , chemotherapy medication part study . The subject peritonitis . Known human immunodeficiency virus ( HIV ) infection ( document subject 's record ) . The subject cirrhosis liver and/or ascites . Subject American Society Anesthesiology Class 4 5 . Complete removal exist mesh prior hernia repair ( affected area ) possible . The hernia repair require single piece mesh ( adequate overlap beyond margin defect side ) . Subject intact permanent mesh adjacent current hernia repair . Subject 's hernia repair require intraabdominal mesh placement . Surgical technique require surgical bridge repair sole repair . Subject condition , opinion Investigator , would preclude use study device , preclude subject complete followup requirement . Subject pregnant plan become pregnant study period currently breastfeed . Subject alcohol/substance abuse problem relapse within 12 month screen visit . Subject involve another interventional clinical study last 30 day prior ICF signature . Subject part site personnel directly involve study . Subject life expectancy le 2 year time enrollment . Subject know sensitivity Phasix™ Mesh component material ( patient know allergy tetracycline hydrochloride kanamycin sulfate avoid ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>